Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol

Clinical trial NCT05094609 · COMPLETED

Trial details

NCT number: NCT05094609
Sponsor: McMaster University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 SARS-CoV2 Infection

Start date: 2022-01-03
Primary completion: 2025-01-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.